HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dora Natalini Selected Research

Dora Natalini Research Topics

Disease

8Neoplasms (Cancer)
12/2023 - 01/2020
5Breast Neoplasms (Breast Cancer)
12/2023 - 01/2019
2Neoplasm Metastasis (Metastasis)
01/2022 - 01/2020
2Neuroblastoma
02/2021 - 01/2020
1Nervous System Diseases (Neurological Disorders)
08/2022
1Adenocarcinoma
01/2022
1Metaplasia
01/2022
1Pancreatitis
01/2022

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
11/2023 - 01/2019
2Biomarkers (Surrogate Marker)IBA
12/2023 - 11/2023
2CholesterolIBA
12/2023 - 01/2022
1SterolsIBA
12/2023
1Terpenes (Terpenoids)IBA
12/2023
1Oxidoreductases (Dehydrogenase)IBA
12/2023
1Mevalonic Acid (Mevalonate)IBA
12/2023
1EnzymesIBA
12/2023
1CateninsIBA
11/2023
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
11/2023
1CytokinesIBA
11/2023
1NucleotidesIBA
03/2022
1Glutamine (L-Glutamine)FDA Link
03/2022
1MicroRNAs (MicroRNA)IBA
03/2022
1Glucose (Dextrose)FDA LinkGeneric
03/2022
1Zoledronic Acid (Zometa)FDA Link
01/2022
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2022
1LipidsIBA
01/2022
1Hormones (Hormone)IBA
01/2022
1SteroidsIBA
01/2022
1Vitamin DFDA LinkGeneric
01/2022
1Messenger RNA (mRNA)IBA
02/2021
1Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA
01/2020
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2019

Therapy/Procedure

1Therapeutics
01/2023